Early data provide reassurance ...

Women who received treatment for autoimmune diseases with CAR T cell therapy went on to have regular pregnancies and healthy ...

Every encounter between a T cell and a potential target—especially when that target is a developing tumor—begins with a rapid ...

Immune cells protect and heal the human body. In medicine, they are specifically activated through biochemical reactions to ...

CellOrigin, a biotechnology company focused on next-generation in vivo and in vitro cell therapy technologies, has announced two major progresses in both research and strategic partnership. At the ...

New research led by Harvard Medical School investigators at Massachusetts General Hospital, Dana-Farber Cancer Institute, and ...

For years, one of the most powerful weapons against certain blood cancers, called CAR-T therapy, has required an elaborate process: Doctors extract a patient’s immune cells, ship them to a specialized ...

Off-the-shelf and mass-producible immune cells fight solid human tumors engrafted into mice. The Kobe University development is a significant contribution towards faster and cheaper cancer ...

On February 13, Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative allogeneic chimeric antigen receptor (CAR) T-cell therapy ...

Researchers say their achievement represents an important step toward the development of a new immunotherapy for solid tumors ...